Oxford genetics secures $2m for bioproduction optimisation R&D

By Dan Stanton

- Last updated on GMT


Related tags Dna

Oxford Genetics hopes to provide improved bioinformatics in order to optimise mammalian bioproduction through a £1.6m grant.

The £1.61m ($2m) grant from Innovate UK was secured by Oxford genetics in order to undertake a research project exploring computational and synthetic biology approaches for optimising mammalian biomanufacturing processes.

“The production yields of many biological drugs are often very low, or at least unpredictable or variable,”​ CEO Ryan Cawood told Biopharma-Reporter.com. “For this reason by using statistical analysis to try and remove any uncertainty by designing proteins, viruses and cells better we can reduce these challenges.”

The funding will be spent primarily on internal research over a three year period, done in collaboration with the University of Oxford.

“The grant aims to deliver services to our biopharmaceutical clients by providing improved bioinformatics and software, coupled with a range of in house tools that we can help to deliver consistency and high productivity in the services we provide,”​ Cawood said. 

The news comes a month after Oxford Genetics secured a $1m grant​ – also from Innovate UK – to conduct research into increasing the efficiency and reducing the cost of scaling-up viral vector production.

Related news

Show more

Related products

show more

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Riding the mRNA Highway

Riding the mRNA Highway

Content provided by Thermo Fisher Scientific - Biosciences | 15-May-2023 | White Paper

Learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications.

Related suppliers

Follow us


View more